Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy-induced thoracic malignancies.

Lydia B Zablotska1, Anne H Angevine, Alfred I Neugut

  • 1Department of Epidemiology, Mailman School of Public Health, Columbia University, 722 West 168th Street, New York, NY 10032, USA.

Clinics in Chest Medicine
|April 6, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of Neoadjuvant Chemotherapy With Overall Survival in Women With Metastatic Endometrial Cancer.

JAMA network open·2020
Same author

A joint industry-sponsored data monitoring committee model for observational, retrospective drug safety studies in the real-world setting.

Pharmacoepidemiology and drug safety·2020
Same author

Low Subcutaneous Adiposity and Mortality in Esophageal Cancer.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2020
Same author

A comparison of complete pathologic response rates following neoadjuvant chemotherapy among South African breast cancer patients with and without concurrent HIV infection.

Breast cancer research and treatment·2020
Same author

Cost of care for the initial management of cervical cancer in women with commercial insurance.

American journal of obstetrics and gynecology·2020
Same author

Insurance-Associated Disparities in Opioid Use and Misuse Among Patients Undergoing Gynecologic Surgery for Benign Indications.

Obstetrics and gynecology·2020
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Cancer survivors face increased risk of secondary thoracic cancers, like lung cancer, after radiation therapy. Clinicians need heightened vigilance for symptoms in these patients, as screening guidelines are lacking.

Area of Science:

  • Oncology
  • Radiation Oncology
  • Cancer Survivorship

Background:

  • The growing population of cancer survivors presents unique long-term health challenges.
  • Therapy-related second primary malignancies (SPMs) are a significant concern for patients treated for initial cancers.
  • Thoracic malignancies, including lung cancer, esophageal cancer, and pleural mesothelioma, are potential SPMs.

Purpose of the Study:

  • To highlight the risk of therapy-induced second primary thoracic malignancies in cancer survivors.
  • To emphasize the need for clinician awareness regarding these risks.
  • To underscore the importance of vigilant monitoring for symptoms of thoracic malignancies in at-risk populations.

Main Methods:

  • This is a review and discussion of existing knowledge on therapy-related second primary malignancies.

Related Experiment Videos

  • Focuses on the implications of prior radiation therapy for thoracic cancer development.
  • Highlights the lack of established screening guidelines for cancer survivors.

    • Main Results:

    • Cancer survivors, particularly those receiving radiation therapy, are susceptible to developing secondary thoracic malignancies.
    • Previous radiation exposure, even if remote, can increase the risk of these tumors.
    • No routine screening guidelines currently exist for detecting these specific secondary cancers in survivors.

    Conclusions:

    • Clinicians must maintain a high level of awareness regarding the potential for radiation-induced second primary thoracic tumors in cancer survivors.
    • Vigilance for signs and symptoms of lung cancer, esophageal cancer, and pleural mesothelioma is crucial in patients with a history of radiation exposure.
    • Further research and guideline development are needed for effective screening and management of SPMs in this growing patient population.